GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Net Margin %

Biosino Bio-Technology and Science (HKSE:08247) Net Margin % : -7.20% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Biosino Bio-Technology and Science's Net Income for the three months ended in Dec. 2023 was HK$-6.2 Mil. Biosino Bio-Technology and Science's Revenue for the three months ended in Dec. 2023 was HK$85.9 Mil. Therefore, Biosino Bio-Technology and Science's net margin for the quarter that ended in Dec. 2023 was -7.20%.

The historical rank and industry rank for Biosino Bio-Technology and Science's Net Margin % or its related term are showing as below:

HKSE:08247' s Net Margin % Range Over the Past 10 Years
Min: -27.78   Med: 0.52   Max: 8.53
Current: -4.08


HKSE:08247's Net Margin % is ranked better than
55.05% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.535 vs HKSE:08247: -4.08

Biosino Bio-Technology and Science Net Margin % Historical Data

The historical data trend for Biosino Bio-Technology and Science's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Net Margin % Chart

Biosino Bio-Technology and Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.78 0.84 -0.33 2.17 -4.03

Biosino Bio-Technology and Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.25 -7.22 -0.43 -0.80 -7.20

Competitive Comparison of Biosino Bio-Technology and Science's Net Margin %

For the Diagnostics & Research subindustry, Biosino Bio-Technology and Science's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosino Bio-Technology and Science's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biosino Bio-Technology and Science's Net Margin % distribution charts can be found below:

* The bar in red indicates where Biosino Bio-Technology and Science's Net Margin % falls into.



Biosino Bio-Technology and Science Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Biosino Bio-Technology and Science's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-12.74/316.182
=-4.03 %

Biosino Bio-Technology and Science's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-6.185/85.871
=-7.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosino Bio-Technology and Science  (HKSE:08247) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Biosino Bio-Technology and Science Net Margin % Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosino Bio-Technology and Science (HKSE:08247) Business Description

Traded in Other Exchanges
N/A
Address
No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.
Executives
Beijing Enterprises Group Company Limited 2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited 2101 Beneficial owner
Hk Zhixin Investment Co., Ltd. 2101 Beneficial owner
Li Dongfeng 2201 Interest of corporation controlled by you
Yan Kang 2201 Interest of corporation controlled by you
Qiu Zhe Feng 2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Li Yang Yi Xiong 2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines